About Careers MedBlog Contact us

WHO Member-Countries Commit To End Tuberculosis By 2030

by Colleen Fleiss on March 16, 2018 at 2:29 AM
Font : A-A+

WHO Member-Countries Commit To End Tuberculosis By 2030

Member-countries of the World Health Organization (WHO) South-East Asia Region, including India committed to intensifying efforts to eradicate tuberculosis by 2030, revealed sources.

"The member-countries unanimously agreed to actualise and intensify essential actions agreed to in the Delhi Call to Action, adopted in March last year, to accelerate efforts to end TB in the region," a statement adopted at the two-day Delhi End TB Summit that concluded here said.


The summit sets the stage for the September 2018 United Nations high-level meeting on TB, wherein the issue will be discussed at the Heads of State level. The UN meeting is likely to endorse a set of goals to put the world on course to ending TB.

The WHO South-East Asia Region, which comprises 11 countries including North Korea and India, is host to one fourth of the global population but a disproportionate 46 per cent of the global TB burden.

"Progress against TB in this region will have a major impact on the global progress. Too much is at stake, we cannot afford to fail," said Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization.

On Tuesday, the Health Ministry and the WHO signed an agreement for enhanced cooperation in the health sector.

WHO's Tedros met Union Health and Family Welfare Minister J.P. Nadda and complimented the government's bold initiatives to expand universal health coverage through Ayushman Bharat.

An apex government body for biomedical research, Indian Council of Medical Research (ICMR) functioning under the Health Ministry was awarded the International Kochon Prize 2017 for contribution to the National Programme in Tuberculosis research on Tuesday.

ICMR through its TB consortium has accelerated efforts for research and development of TB in the country. The TB consortium is working with public and private institutes to guide the country's research towards development of point-of-care diagnostics, shorter treatment regimens, and effective vaccine for tuberculosis.

The Kochon Prize, endowed by the Kochon Foundation, a non-profit foundation registered in the Republic of Korea, consists of $65,000 award.

The summit, inaugurated by Prime Minister Narendra Modi on Tuesday, was attended by the Health Ministers number of countries, including Sri Lanka, Indonesia, Bangladesh, Nigeria, Mozambique, Zimbabwe, Kazakhstan and Peru.

Source: IANS


Recommended Reading

Latest Respiratory Disease News

Emerging Respiratory Threat - Human Metapneumovirus (HMPV)
According to the Centers for Disease Control and Prevention (CDC), there was a notable increase in infections caused by human metapneumovirus (HMPV), an emerging threat.
Is Lab-Grown Mini Lungs the Key to Understanding Respiratory Diseases?
The new cell culture technology platform allows researchers to react to the next pandemic with much more speed and precision.
 Artificial Intelligence-enabled Chest Scan Improves Pulmonary Hypertension Diagnosis
A new artificial intelligence-enabled chest imaging technology performs a deep characterization of the pulmonary vasculature to detect pulmonary (arterial) hypertension.
Could a Severe Heatwave Lead to Asthma?
The global climate crisis is stimulating heat waves to become more frequent causing distress to people with asthma, say experts.
Why Is Vitamin D3 Essential for Allergic Asthma?
A new study reveals vitamin D3 supplements have encouraging effects for asthma patients. Vitamin D has a positive effect on immune response.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

WHO Member-Countries Commit To End Tuberculosis By 2030 Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests